195 related articles for article (PubMed ID: 22363680)
1. Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells.
Chiu HW; Chen YA; Ho SY; Wang YJ
PLoS One; 2012; 7(2):e31579. PubMed ID: 22363680
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways.
Chiu HW; Ho SY; Guo HR; Wang YJ
Autophagy; 2009 May; 5(4):472-83. PubMed ID: 19242099
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis.
Chiu HW; Lin JH; Chen YA; Ho SY; Wang YJ
Autophagy; 2010 Apr; 6(3):353-65. PubMed ID: 20200477
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
Chiu HW; Ho YS; Wang YJ
J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis.
Chiu HW; Lin W; Ho SY; Wang YJ
Radiat Res; 2011 May; 175(5):547-60. PubMed ID: 21388295
[TBL] [Abstract][Full Text] [Related]
6. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
[TBL] [Abstract][Full Text] [Related]
7. Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy.
Chiu HW; Fang WH; Chen YL; Wu MD; Yuan GF; Ho SY; Wang YJ
PLoS One; 2012; 7(7):e40462. PubMed ID: 22802963
[TBL] [Abstract][Full Text] [Related]
8. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.
Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH
Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728
[TBL] [Abstract][Full Text] [Related]
9. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
Kumagai T; Ikezoe T; Gui D; O'Kelly J; Tong XJ; Cohen FJ; Said JW; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(4):1508-20. PubMed ID: 14977855
[TBL] [Abstract][Full Text] [Related]
10. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
[TBL] [Abstract][Full Text] [Related]
12. Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells.
Tai S; Xu L; Xu M; Zhang L; Zhang Y; Zhang K; Zhang L; Liang C
Oncotarget; 2017 Feb; 8(7):11206-11218. PubMed ID: 28061438
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3).
Chun YJ; Park IC; Park MJ; Woo SH; Hong SI; Chung HY; Kim TH; Lee YS; Rhee CH; Lee SJ
FEBS Lett; 2002 May; 519(1-3):195-200. PubMed ID: 12023044
[TBL] [Abstract][Full Text] [Related]
15. Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway.
Wang X; Ren JH; Lin F; Wei JX; Long M; Yan L; Zhang HZ
Cancer Biol Ther; 2010 Sep; 10(6):632-43. PubMed ID: 20657188
[TBL] [Abstract][Full Text] [Related]
16. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer.
Guilbert C; Annis MG; Dong Z; Siegel PM; Miller WH; Mann KK
PLoS One; 2013; 8(12):e85995. PubMed ID: 24392034
[TBL] [Abstract][Full Text] [Related]
18. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
[TBL] [Abstract][Full Text] [Related]
19. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
20. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
